tiprankstipranks
Brainsway (BRSYF)
:BRSYF
US Market

Brainsway (BRSYF) Earnings Dates, Call Summary & Reports

Compare
8 Followers

Earnings Data

Report Date
Apr 01, 2025
TBA Not Confirmed
Period Ending
2024 (Q4)
Consensus EPS Forecast
Last Year’s EPS
0.02
Same Quarter Last Year
Based on 0 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Nov 12, 2024
|
% Change Since: 83.81%
|
Next Earnings Date:Apr 01, 2025
Earnings Call Sentiment|Positive
The earnings call was largely positive, driven by significant revenue growth, strong financial performance, strategic investments, and international expansion. However, increased operating expenses and dependence on future regulatory approvals present challenges.
Company Guidance
During the BrainsWay Third Quarter 2024 Earnings Conference Call, the company provided strong guidance for the remainder of the fiscal year. They reported a 26% year-over-year increase in revenue to $10.5 million for Q3 2024, with a positive net income for the fourth consecutive quarter. The company revised its full-year 2024 revenue guidance upward to a range of $40 million to $41 million, representing a 26% to 29% growth over the previous year. They also introduced profitability guidance, expecting an operating income of 3% to 4% and adjusted EBITDA of 10% to 11% for the full year. BrainsWay emphasized its strategic investments in developing the next-generation Deep TMS 360 system, conducting clinical trials to expand treatment capabilities, and enhancing commercial presence. With a pro forma cash position of approximately $68.4 million, the company is poised to leverage its resources for growth and maintain positive cash flow and profitability.
Significant Revenue Growth
BrainsWay reported a 26% year-over-year increase in revenue for Q3 2024, reaching $10.5 million. Full-year 2024 revenue guidance was increased to $40-41 million, representing 26% to 29% growth over 2023.
Positive Financial Performance
BrainsWay achieved positive quarterly net income for the fourth consecutive quarter and positive adjusted EBITDA and cash flow from operations for the fifth consecutive quarter. Q3 2024 net income was approximately $650,000, compared to a net loss of $230,000 in Q3 2023.
Strategic Investment and Strong Cash Position
BrainsWay completed a strategic private investment equity financing with Valor Equity Partners for approximately $20 million, bringing the pro forma cash position to $68.4 million.
Expansion in International Markets
BrainsWay placed 15 new Deep TMS systems in Taiwan and South Korea, indicating continued commercial success in the East Asian market.
Regulatory and Reimbursement Achievements
Approval for the reimbursement of Deep TMS therapy for PTSD patients by the Israeli Ministry of Defense Rehabilitation Department was granted.
Clinical and R&D Progress
BrainsWay's multicenter clinical trial for an accelerated treatment protocol is fully underway, with potential FDA approval in 2025.
---

Brainsway (BRSYF) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

BRSYF Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Apr 01, 20252024 (Q4)
- / -
0.004
Nov 12, 20242024 (Q3)
- / 0.02
-0.007384.62% (+0.03)
Aug 06, 20242024 (Q2)
- / 0.02
-0.051136.61% (+0.07)
May 08, 20242024 (Q1)
- / <0.01
-0.073104.63% (+0.08)
Mar 06, 20242023 (Q4)
- / <0.01
-0.115103.68% (+0.12)
Nov 15, 20232023 (Q3)
- / >-0.01
-0.14694.99% (+0.14)
Aug 09, 20232023 (Q2)
- / -0.05
-0.0726.51% (+0.02)
May 17, 20232023 (Q1)
- / -0.07
-0.054-34.20% (-0.02)
Mar 15, 20232022 (Q4)
- / -0.11
-0.036-216.28% (-0.08)
Nov 16, 20222022 (Q3)
- / -0.15
-0.05-193.22% (-0.10)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

BRSYF Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 12, 2024$3.15$3.150.00%
Aug 06, 2024$2.10$2.100.00%
May 08, 2024$2.47$2.470.00%
Mar 06, 2024$1.90$1.900.00%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Brainsway (BRSYF) report earnings?
Brainsway (BRSYF) is schdueled to report earning on Apr 01, 2025, TBA Not Confirmed.
    What is Brainsway (BRSYF) earnings time?
    Brainsway (BRSYF) earnings time is at Apr 01, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is BRSYF EPS forecast?
          Currently, no data Available
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis